bpc-157 bladder pain pilot study Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-System What is BPC-157 and How
Description
cancer.gov 2016 [Cited 21 August 2019]
At a dose of 0.5 mg/kg, Dihexa completely reversed scopolamine-induced cognitive deficits in rat models
Discuss your individual circumstances with your GP, who can assess whether testing or supplementation is appropriate for you
Data availability Not applicable
To see the best results, regular sessions are recommended based on your health goals
